Literature DB >> 18475038

Relationship between radiation pneumonitis and prognosis in patients with primary lung cancer treated by radiotherapy.

Mototsugu Yamano1, Hiroyuki Ogino, Yuta Shibamoto, Naotoshi Horii.   

Abstract

Relationship between the grade of radiation pneumonitis (RP) and treatment outcome in lung cancer patients has not been clarified yet. The purpose of this study was to retrospectively evaluate the relationship in patients with primary lung cancer treated by radiotherapy. One hundred thirty-five patients who underwent definitive radiotherapy with known grade of RP were analyzed. RP was scored by using the Radiation Therapy Oncology Group (RTOG) acute radiation morbidity scoring criteria. Survival and local control data were analyzed in relation to the grade of RP. RP was grade 0 in 5 patients, grade 1 in 71, grade 2 in 39, grade 3 in 15 (11%), grade 4 in 0 and grade 5 in 5 (3.7%). There were no significant correlations between patient or tumor characteristics and grade of RP. Excluding 5 patients with grade 5 pneumonitis, survival rates were similar between those with grade 0 or 1 pneumonitis and those with grade 2 or 3. Also, there was no difference in survival between patients with grade 0-2 pneumonitis and those with grade 3. Local control rates were similar between the two groups. Grade of RP did not appear to be associated with prognosis when patients with grade 5 pneumonitis were excluded from analysis.

Entities:  

Mesh:

Year:  2007        PMID: 18475038     DOI: 10.2739/kurumemedj.54.57

Source DB:  PubMed          Journal:  Kurume Med J        ISSN: 0023-5679


  2 in total

Review 1.  Prediction of radiation pneumonitis in lung cancer patients: a systematic review.

Authors:  Xiao-Jing Zhang; Jian-Guo Sun; Jie Sun; Hua Ming; Xin-Xin Wang; Lei Wu; Zheng-Tang Chen
Journal:  J Cancer Res Clin Oncol       Date:  2012-07-29       Impact factor: 4.553

2.  Polymorphisms of homologous recombination genes and clinical outcomes of non-small cell lung cancer patients treated with definitive radiotherapy.

Authors:  Ming Yin; Zhongxing Liao; Yu-Jing Huang; Zhensheng Liu; Xianglin Yuan; Daniel Gomez; Li-E Wang; Qingyi Wei
Journal:  PLoS One       Date:  2011-05-25       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.